Fundraising Fox

SeqOne

3 known investors

Find your way into SeqOne

77 people in our graph share verified history with the SeqOne team — schools, employers, funds. One of them is your warm intro.

Laurie Menoudunlockedknows Nicolas Philippe · together at CNRS - National center for scientific research (overlapped)
×7knows the team · via CNRS - National center for scientific research
×4knows the team · via INSERM

SeqOne provides a clinical genomics analysis platform for germline and somatic variant interpretation across panels, exomes, and genomes, supporting short and long-read sequencing. It offers tools such as a DiagAI variant-prioritization score and an automated data pipeline (SeqOne Flow), serving diagnostic labs and clinical genomics teams with a CE-IVD certified in vitro diagnostic medical device.

AI & Machine LearningBiotechDigital Health

Founders & leadership

NPNicolas Philippe
Nicolas PhilippeinFounderNicolas Philippe has worked on high-throughput (NGS) sequencing since beginning his PhD in 2007, spanning mathematical and computational analysis of sequencing data, bioinformatics tool development, and a postdoctoral focus on biomedical problems and genomic biomarker discovery. He founded SeqOne in March 2017, a company offering a bioinformatics platform for analyzing genetic sequencing data in medical laboratories.

Investors · 3

Mérieux Equity PartnersParis · $3.2M – $86M
Supernova InvestParis
Elaiareported · 2 sourcesParis · $108K – $1.6M

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

In the news

SeqOne acquires Congenica to create a global leader in AI-powered genomic medicineblog.congenica.com · Sep 2025SeqOne Secures €20M Growth Funding | The SaaS Newsthesaasnews.com · May 2025Medpathtrial.medpath.com · May 2025SeqOne raises €20M to expand AI-powered genetic diagnostics platform - FoundersTodayfounderstoday.news · May 2025SeqOne Genomics Raises €20 Million in Oversubscribed Growth Round to Lead AI-Powered NGS Revolution in Personalized Medicine - Omnes Capitalomnescapital.com · May 2025SeqOne Genomics Closes €20M Series A Financing | GenomeWebgenomeweb.com · Jan 2022

Frequently asked questions

What does SeqOne do?
SeqOne provides a clinical genomics analysis platform for germline and somatic variant interpretation across panels, exomes, and genomes, supporting short and long-read sequencing. It offers tools such as a DiagAI variant-prioritization score and an automated data pipeline (SeqOne Flow), serving diagnostic labs and clinical genomics teams with a CE-IVD certified in vitro diagnostic medical device.
Who founded SeqOne?
SeqOne was founded by Nicolas Philippe.
Who are SeqOne's investors?
SeqOne's investors include Mérieux Equity Partners, Supernova Invest, Elaia.